507 related articles for article (PubMed ID: 35174781)
1. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
3. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
[TBL] [Abstract][Full Text] [Related]
4. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
7. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
[TBL] [Abstract][Full Text] [Related]
8. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization.
Mizutani T; Ishizaka A; Koga M; Ikeuchi K; Saito M; Adachi E; Yamayoshi S; Iwatsuki-Horimoto K; Yasuhara A; Kiyono H; Matano T; Suzuki Y; Tsutsumi T; Kawaoka Y; Yotsuyanagi H
Microbiol Spectr; 2022 Apr; 10(2):e0168921. PubMed ID: 35254122
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
[TBL] [Abstract][Full Text] [Related]
10. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the gut microbiota in patients with chronic kidney disease.
Hu X; Ouyang S; Xie Y; Gong Z; Du J
Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
[No Abstract] [Full Text] [Related]
12. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
[TBL] [Abstract][Full Text] [Related]
13. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
Wu Y; Cheng X; Jiang G; Tang H; Ming S; Tang L; Lu J; Guo C; Shan H; Huang X
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):61. PubMed ID: 34294722
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Washed Microbiota Transplantation to Treat Patients with Mild-to-Severe COVID-19 and Suspected of Having Gut Microbiota Dysbiosis: Study Protocol for a Randomized Controlled Trial.
Wu LH; Ye ZN; Peng P; Xie WR; Xu JT; Zhang XY; Xia HH; He XX
Curr Med Sci; 2021 Dec; 41(6):1087-1095. PubMed ID: 34846698
[TBL] [Abstract][Full Text] [Related]
15. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
[TBL] [Abstract][Full Text] [Related]
16. A metagenomic study of the gut microbiome in Behcet's disease.
Ye Z; Zhang N; Wu C; Zhang X; Wang Q; Huang X; Du L; Cao Q; Tang J; Zhou C; Hou S; He Y; Xu Q; Xiong X; Kijlstra A; Qin N; Yang P
Microbiome; 2018 Aug; 6(1):135. PubMed ID: 30077182
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19.
Trøseid M; Holter JC; Holm K; Vestad B; Sazonova T; Granerud BK; Dyrhol-Riise AM; Holten AR; Tonby K; Kildal AB; Heggelund L; Tveita A; Bøe S; Müller KE; Jenum S; Hov JR; Ueland T;
Crit Care; 2023 Feb; 27(1):69. PubMed ID: 36814280
[TBL] [Abstract][Full Text] [Related]
19. Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.
Prasad R; Patton MJ; Floyd JL; Fortmann S; DuPont M; Harbour A; Wright J; Lamendella R; Stevens BR; Oudit GY; Grant MB
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012406
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiome and Cytokine Profiles in Post-COVID Syndrome.
Mussabay K; Kozhakhmetov S; Dusmagambetov M; Mynzhanova A; Nurgaziyev M; Jarmukhanov Z; Vinogradova E; Dusmagambetova A; Daulbaeva A; Chulenbayeva L; Tauekelova A; Bekbossynova M; Kushugulova A
Viruses; 2024 May; 16(5):. PubMed ID: 38793604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
